New Genetic Links Between Type 1 Diabetes, Insulin Secretion, and Insulin Resistance

Type 1 diabetes is an autoimmune disease, meaning the immune system attacks the insulin-producing cells in the pancreas. Scientists have long known that genetics play a major role in determining who develops the disease. However, the full picture of which genes are involved—and how they work—remains incomplete, especially when looking across people from different ancestral backgrounds.

A new study published in Diabetologia examined genetic data from over 62,000 people across diverse ancestries to map out the genetic architecture of Type 1 diabetes. The researchers identified 69 genetic regions associated with disease risk, including three previously unknown regions. This broader, more inclusive approach helps ensure that genetic discoveries benefit people from all backgrounds, not just those of European descent.

The study uncovered three novel genetic variants associated with Type 1 diabetes risk. These variants are located near or within genes called AHI1, TRAF1, and ADCY7. While these findings are statistically significant, it's important to understand that identifying a genetic variant associated with disease risk does not mean it directly causes the disease—rather, it flags a region worth further investigation.

Each of these variants showed a modest increase in disease risk. The researchers used rigorous statistical methods to confirm these signals and to prioritize which genetic variants within these regions are most likely to have real biological effects.

One of the study's most intriguing findings is that more than one-third of the 69 genetic variants linked to Type 1 diabetes risk are also associated with measures of insulin secretion or insulin resistance. This is noteworthy because Type 1 diabetes is primarily an autoimmune disease—the immune system is attacking insulin-producing cells. Yet many of the genetic risk factors appear to be involved in how insulin is made and used.

This overlap suggests that Type 1 diabetes susceptibility may not be solely determined by immune system genetics. Instead, a person's genetic factors related to insulin production and insulin sensitivity may also play a role in disease development. The researchers identified 136 specific genetic variants that are likely to have functional effects on these processes.

By studying genetic patterns across diverse ancestral populations, researchers can identify risk factors that apply more broadly to humanity, rather than to a single group. This study's multi-ancestry approach strengthens confidence that these findings are relevant to Type 1 diabetes prevention and treatment across different populations.

The connection between Type 1 diabetes risk genes and insulin function opens new questions: Do genetic variants affecting insulin secretion or sensitivity make the body more vulnerable to autoimmune attack? Do they influence how quickly the disease progresses? Future research will be needed to answer these questions and to understand whether these genetic insights could eventually lead to better ways to predict, prevent, or delay Type 1 diabetes onset.

Source: Diabetologia. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.